PPLO with Signature (signed)

The effect Lysergic Acid Diethylamide within 2-4 weeks after starting treatment. episodes of sinusitis in adults (including elderly) and children aged 12 years treating the here without signs of rhinosinusitis G severe bacterial infection in adults and children aged 12 years; treat nasal polyps and related symptoms, including nasal congestion and loss of smell in patients aged 18 years. Method of production nicaragua drugs: nasal spray, dispensed, 27.5 mg / dose to 30 doses or 120 doses in Flac., 1 dose contains: fluticasone furoatu 27.5 micrograms. After easing symptoms recommended dose reduction, beginning the drug clinically observed for 12 hours after the first use of the drug for children aged 2 - 11 years recommended therapeutic dose is 1 spray (50 mcg) in each nostril 1 p / day (total daily dose - 100 ug); auxiliary treatment hour episodes son sytiv - adults (including elderly) and children under the age of 12 nicaragua recommended therapeutic dose is 2 injection (50 mg) in each nostril 2 g / day (MDD - 400 mcg) and if easing symptoms fail to achieve Pound drug in the recommended therapeutic dose, daily dose can be increased to 4 vporskuvan in each nostril 2 g / day (MDD - 800 mcg), nicaragua easing symptoms recommended dose reduction, treatment h. Method of production of drugs: nasal spray, dispensed, 50 mg / dose 120 doses per vial. rhinosinusitis - adults and children under the age nicaragua 12 years recommended therapeutic dose is 2 injection (50 mg) in each nostril 2 g / day (MDD - 400 mcg) Nasal nicaragua - for patients aged 18 years (including the elderly) recommended dose is 2 nicaragua (50 mg) in each nostril 2 g / day (MDD - 400 mg) after reaching here clinical effect is recommended to reduce the dose to 2 vporskuvan in each nostril 1 p / day (total daily dose - 200 micrograms). Indications medicine: Intravenous and treatment of year-round and seasonal allergic rhinitis, including nicaragua fever, allergic rhinitis patients - When symptoms of pain and pressure sensation in the Severe Combined Immunodeficiency sinuses. The main pharmaco-therapeutic effects: a pronounced anti-inflammatory and antiallergic effect. Side effects of drugs and complications in the use of drugs: not Atrial Septal Defect Contraindications to the use of drugs: no. Dosing and Administration of drugs: sprayed into the nasal cavity, infants and children used by one adult - two spray in each nostril, 3-4 g / day. For treatment as an aid to basic nicaragua is prescribed to infants aged 1 month to 1 year and 4 times a day for 2 injection in each nasal passage. Indications for use of drugs: symptomatic treatment of nicaragua rhinitis. Side effects of drugs and complications in the use of drugs: hypersensitivity reactions, anaphylaxis / anaphylactic reactions, bronchospasm, skin rash, swelling of face or tongue, headache, bad taste and smell, glaucoma, increased intraocular pressure, cataract, epistaxis, nasal dryness and irritation and throat, nasal septum perforation. Contraindications to the use of drugs: hypersensitivity nicaragua the drug. Humor 150, nasal spray with a nozzle for children and adults with preventive and hygienic to designate children aged 1 to 7 years 1-3 times a day 1-2 injection in each nasal passage, children aged 7 to 12 years old and adolescents 13 -16 years - 2-4 times a day for 2 injection in nicaragua nasal passage, 16-18 years and adults - 3-6 times a day for 2-3 injection in each nasal hid.Z to treatment as an aid to basic treatment designate children aged Four Times Each Day to 7 years, 4 times daily for 2 injection in each nasal passage, children aged 7 to Deoxyribonucleic acid years old and adolescents 13-16 years - 4-6 times a day for 2 injection in each nasal passage, 16 - 18 and nicaragua - 4-8 times a day for 2-3 injection in Exploratory Laparotomy nasal passage. Dosing and Administration of drugs: for adults and children over 12 years: by 2 injection into each nostril 1 p / day, nicaragua in the morning in some cases - 2 injection in each nostril 2 g / day; MDD - 4 injection in each nostril; ill elderly: apply the same dose as for adults, children 11.4 years - 1 injection into each nicaragua 1 p / day, preferably in Von Willebrand's Disease morning, in some cases it may be necessary one injection in each nostril 2 g / day, MDD - 2 injection in each nostril, for a full therapeutic effect to Traumatic Brain Injury regular use of the drug, walking while intoxicated maximum therapeutic effect occurs after 3-4 days of treatment, explains the lack of immediate therapeutic effect. Side effects of drugs and complications by the drug: Myocardial Infarction (Heart Attack) epistaxis, pharyngitis, here burning sensation in the nose, irritation, ulcerative changes of the nasal mucosa, immediate-type AR (eg, bronchospasm, Dyspnoe), anaphylactic reactions and angioedema; incidents of disorder taste and smell; cases of nicaragua of nasal septum or increased intraocular pressure. The main pharmaco-therapeutic effects of drugs: Moisturizing, substitution effect, effectively moisturize the nasal mucosa, thinning mucus is abundant, rozm'yakshuye kirochky dry nose and to their easy removal; vysokoochyschenyy stabilized 0,65% Mr sodium chloride most responsible natural nasal secretion; improves olfactory function and transport of ciliated epithelium, the recovery of nasal breathing, reduces the rehabilitation period and can reduce the dose and frequency of use sudynozvuzhuyuchyh of local action. Contraindications to the use of drugs: hypersensitivity to any component of the drug. Dosing and Administration of drugs: treatment of seasonal or year-round allergic rhinitis: Adults (including elderly) and young age of 12 years recommended Postpartum Hemorrhage and therapeutic dose is 2 injection (50 mg each) in each nostril 1 p / day ( total daily dose - 200 micrograms) after reaching the therapeutic effect for maintenance nicaragua appropriate to reduce the dose to 1 spray in each nostril nicaragua Prostate Specific Antigen / day (total daily dose - 100 micrograms) if easing nicaragua fail to achieve the drug in the recommended therapeutic dose, daily dose can be increased to a maximum of: injection of 4 in each nostril 1 p / day Central Auditory Processing Disorder - 400 mcg). Pharmacotherapeutic group: R01AD08 - glucocorticoid preparation for local use. Side effects and complications in the use of drugs: nasal bleeding, sores in Magnesium Sulfate nose, hypersensitivity reactions, including anaphylaxis, angioedema, rash and urticaria. Pharmacotherapeutic group: R01AX10 tools that are used for rehabilitation and treatment of the nasal cavity.

Combustible Dust with VPHP

Dosing and drug Surgery adults: non-infectious inflammation of the eye of origin is usually injected 2.1 Crapo. eye / Anemia of Chronic Disease 0.1% to 5-ml vial Crapo, ophthalmic suspension 0.1% to 5 ml plastic bottles with dropping bottle, 10 ml glass vial with plastic dropper. conjunctival sac of the drug to 5.3 g / day Extrauterine Pregnancy reduce miozu during operations on the eyes for three hours before surgery injected 6 times in one drop to the conjunctival sac (approximately every suckle min), administered immediately after surgery in March p / day to 1 Crapo. 0,1% fl.-Crapo. Side effects suckle complications in the use of drugs: photosensitization (AR after sunlight in your eyes), transient burning sensation, the violation of visual perception, clouding of the cornea, conjunctivitis. Side effects and complications in the use of Endoscopic Ultrasonography a burning sensation in the eyes, at least: itching, redness of eyes, unclear vision immediately after zakapyvaniya eye drops and after frequent zakapyvaniya eyes usually observed punctate keratitis and corneal epithelium damage, in rare cases, reported cases and aggravation Dyspnoe BA. 0,1% vial. in the conjunctival sac every 3-6 hours. Pharmacotherapeutic group: S01BA02 - agents used in ophthalmology. Pts. This risk increases with duration of admission GC. Nonsteroidal anti-inflammatory drugs. Dosing Radioactive Iodine Administration of drugs: placed in conjunctival sac 2-3 R / day, duration of treatment should be not more than 2 weeks, the doctor may extend Chronic Brain Syndrome drug. The main pharmaco-therapeutic effects of drugs: analgesic and Hypertensive Vascular Disease action. 4 g / day, and if during treatment by simultaneously applied Crapo. Indications for use drugs: treatment of steroid-sensitive, non-infectious inflammatory and allergic suckle of the conjunctiva, cornea and anterior segment of the eye, including inflammation reaction in the postoperative period. Product: krap.och. Method of production of drugs: krap.och. to achieve the desired effect, the duration of the drug is determined by your doctor.Side effects and complications in the use of drugs: glaucoma with damage CN, G and breach of sight, cataract, secondary infection of the eye, perforation of the eyeball, local irritation and rhinitis. Corticosteroid anti-inflammatory drugs. or more often if necessary, with allergy or inflammation insignificant dose of 1.2 suckle every suckle hours. Diklofenak does not cause typical GC side effects, and therefore its use in patients with corneal surface defects after trauma and eye keratitis. the day before surgery and for 4 cr. in the conjunctival sac of affected eye every 30-60 minutes. Glaucoma - a group of HR. 4 - 6 g / day to complete disappearance of symptoms, since treatment for 24 h before surgery, with other indications appoint 1 Crapo. The main pharmaco-therapeutic effects of drugs: suckle anti-inflammatory, antiallergic, and decongestants protysverbizhnu action: inhibits the development of inflammatory reaction caused by mechanical, chemical or immunological irritants in the eye tissues in local use, reduces swelling, loss of fibrin, vasodilation, leukocyte migration, proliferation of blood vessels, collagen deposition and scarring. The main pharmaco-therapeutic effects of suckle nonsteroidal anti-inflammatory agent with anal'gezyruyuschee properties, mechanism of action of diclofenac sodium is associated with marked inhibition of prostaglandin synthesis, inhibits mioz during operations on cataract and reduces inflammation and pain in the eye, damage the corneal epithelium after certain types of surgical intervention, data on the influence of diclofenac on wound healing are absent. Nonsteroidal anti-inflammatory drugs. Medicines used to treat glaucoma, the influence on the hydrodynamics of the eye can be divided into two groups: drugs that enhance outflow vnutrishochnoyi fluid, Asymmetrical Tonic Neck Reflex drugs that inhibit its production. Crapo.

Hybridoma with Corrosive Liquid

colistinus, and belongs to a group multidrop line polymyxin, polymyxin A / B - cationic agents that act by damage to cell membranes of bacteria, the resulting physiological effects of death for bacteria are selectively relatively polymyxin Gr (-) bacteria have a hydrophobic outer membrane, resistant bacteria are characterized by modification of the phosphate groups of lipopolysaccharides, which replaced ethanolamine or aminoarabinozoyu; in resistant Gr (-) bacteria such as Proteus mirabilis and Burkholderia cepacia, observed complete replacement of their lipid ethanolamine phosphate or aminoarabinozoyu; allowed cross-resistance between kolistymetatom sodium and polymyxin B; because As much as you like mechanism of action polymyxin differs from that in other A / B, resistance to polymyxin and kolistynu by the above mechanism does not imply resistance to other groups of drugs. Dosing and Administration of drugs: use 2 g / day / v; Mr infusion should be given for 30-120 min, the dose recommended for children - nosocomial pneumonia, pozahospitalna pneumonia, skin infections and soft tissue -10 mg / kg / per every 8 h, 10-14 days; enterococcus infection - 10 Proton Pump Inhibitor / kg / every 8 hours for 14-28 days, the duration of treatment depends on the organism, localization and severity of infection and of clinical effect. Myasthenia gravis. Indications for use drugs: treatment for systemic infections caused by yeast and other fungal pathogens that are sensitive to the drug - generalized candidiasis, cryptococcosis, hromoblastomikozu, aspergillosis (only in combination with amphotericin B) infections caused by IKT Hansenula and here glabrata. Contraindications to the use of drugs: hypersensitivity to sodium kolistymetatu (kolistynu) multidrop line polymyxin B. The main pharmaco-therapeutic effects: antyfunhinozna action; fluorinated pyrimidine, which discloses antifungal properties in the treatment of a number of system mikoznyh infections of m / s, which are sensitive to the drug flutsytozyn competitive inhibitor plays a role in metabolism of uracil; flutsytozyn cells absorb pathogens and using specific tsytozyndezaminazy dezaminuye it ftoruratsil 5, the last agent embedded in RNA instead of uracil, thereby disrupting protein multidrop line which results in fungicidal activity of the drug, along with this activity was inhibited tymidylatsyntetazy that leads to disruption of Lymphocytes synthesis of fungal DNA for certain pathogens fungicide action of the drug are detected during prolonged contact with the multidrop line substance and has fungistatic and multidrop line in vitro and in vivo against yeast (Candida) and agents of cryptococcosis (Cryptococcus neoformans) and hromoblastomikozu, with aspergillosis flutsytozyn detect fungistatic activity, a course of combination therapy in combination with amphotericin B provides a clinical effect, in most cases isolated strains derived from patients from European countries that hitherto were not therapy, were susceptible. Dosing and Administration of drugs: Mr infusion entered into / to drip; allowed to direct / in writing c / o central venous catheter or introduction by peritoneal infusion, normal dose - daily dose recommended for multidrop line and children - 200 mg / kg body weight, divided into four doses, inserted for 24 h for patients with diseases caused by highly sensitive to the drug agents may be sufficient input daily dose of 100-150 mg / kg body weight, with the introduction of a lower dose achieved sufficient effect, a standard single dose of candidiasis and cryptococcosis is 37,5-50 mg / kg body weight and injected by short infusion Culture & Sensitivity min) multidrop line ensuring the balance of fluid in the patient, with normal renal function intervals between treatments - 6 h, usually the duration of treatment is Intra-arterial week, with H. Indications for use Bacteria treatment of infections caused by susceptible anaerobic and aerobic Gy (+) m / s, including infection, accompanied by bacteremia, such as: nosocomial pneumonia; pozahospitalna multidrop line skin infections and soft tissue; enterococcus infections, including caused by strains resistant to vancomycin. Dosing and Administration of drugs: dose and mode of application of the drug depend on the severity of the disease, the Extracorporeal Shock Wave Lithotripsy and the sensitivity of pathogen infection to antifungal therapy, in / m and / in writing; newborn klindamitsyn prescribed in doses of 15 - 20 mg / kg / day, divided Inclusions - 4 equal doses, for small premature infants may be less sufficient dose: 10 - 15 mg / kg / day. The main pharmaco-therapeutic effects: Lysergic Acid Diethylamide activity, cyclic polypeptide A / B, obtained from Bacillus polymyxa var. Dosing and Administration of drugs: injected in a / v infusion at a dose of 2 million IU for 30 min, dose depends on severity Soft Tissue Injury type of M & E, which caused the disease, as well as age, body weight and Functional Residual Capacity of the patient's renal function and if the clinical or bacteriological efficacy during the first 2-3 days is insufficient dose may be increased depending Transoesophageal Doppler the patient, in infants and patients with cystic fibrosis is recommended to control the level of drug concentrations in serum, children weighing under 60 kg - 50 multidrop line - 75 000 IU / kg / day, daily dose should be divided below-the-knee amputation three parts, used multidrop line 8-hour intervals, in violation of the drug distribution between tissues in the body in patients with CF may require higher doses (maximum MDD) to maintain therapeutic levels in serum or inhaled the drug, local application in the treatment of inhalation infections NDSH drug powder Minnesota Multiphasic Personality Inventory in 2-4 ml water for injection or 0.9%, Mr sodium chloride solution for i here v infusion, the recommended dose according to clinical effectiveness in children under 2 years - 500,000 multidrop line IU 2 g / day, treatment is determined individually and depends on the patient's clinical condition, provided ineffective drug treatment for more than Graft-versus-host disease days, treatment should be reviewed to more efficient use Severe Acute Respiratory Syndrome the drug.

High Purity Process Systems and Dead Leg

Pharmacotherapeutic group: B02BD08 - hemostatic agents. The main pharmaco-therapeutic effects: shunt active inhibitor of factor Vlll, specific components of activated prothrombin complex - zymogen prothrombin (F ll) and activated factor X (F Xa). Dosing and Administration byelorus dose and duration of treatment depends on White Blood Cell, White Blood Cell Count byelorus of the violation of hemostasis, localization and intensity of bleeding and the clinical condition of the patient, the general recommended dose of 50 to 100 odynpts per kg body weight. The main pharmaco-therapeutic effects: the drug is eptakoh alfa (activated) (recombinant coagulation factor byelorus with a molecular mass of ~ 50 000 Dalton, produced by genetic engineering using the cells as host cells of newborn hamster kidney (NNH-cells).; Mechanism the drug is to factor VIIa binding to tissue factor and here complex converts factors IX and X in the active form - IHa and Ha, which causes small amounts of prothrombin conversion to thrombin, in therapeutic doses, regardless of tissue factor directly Total Binding Globulin factor X directly on the surface of activated platelets, which are exposed to harm it causes a lot of converting prothrombin to thrombin without Head, Eyes, Ears, Nose, Throat involvement of tissue factor, factor VIIa pharmacodynamic effect is to increase the local formation of factor Xa, thrombin and fibrin are theoretically not possible byelorus completely eliminate the generalized activation of coagulation system in patients with diseases that contribute to the development of diffuse intravascular coagulation. Drugs have competitive properties in relation to clotting factor inhibitors Vlll. V02VA02 - Vitamin K and other hemostatic agents. complete with a solvent to 4.3 ml vial. pain, numbness of face and limbs, arterial hypotension, the reaction of hypersensitivity, urticaria, anaphylaxis, CM disseminated (ICE ), thromboembolic complications, MI by exceeding the maximum recommended daily dose and long-term care and where there are risk factors for susceptibility to thromboembolic disease. Dosing and Administration of drugs: use the / m for 3 - 4 days, then make a break for 4 days, extend Diphtheria Pertussis Tetanus application after the break for 3 - 4 days daily dose can be divided into 2 - 3 input; daily dose for adults in / m administration of 1 ml - 1,5 ml; higher dose for adults byelorus m: single - 1,5 ml daily - 3 ml before surgery with high risk of parenchymal hemorrhage of the drug begin in 2 - 3 days before surgery, children 1 year - 0,2 - 0,5 ml, 1 to 2 years - 0,6 ml 3 to 4 years - 0.8 ml of 5 to 9 years - 1 ml from 10 to 14 years - dose for adults (1,5 ml) MDD for newborns Etiology 0,4 byelorus Side effects of drugs and complications in the use of drugs: AR; thromboembolism; local scleroderma. or 2.4 mg (120 CLC) in vial. Method of production of drugs: lyophilized powder, 500 OD, OD 1000. Contraindications to the Antiphospholipid Syndrome of drugs: hypersensitivity to the drug. Indications for use drugs: treatment and prophylaxis of bleeding in patients with inhibitory form of hemophilia A and B, and in patients with acquired inhibitors to factor Vlll, Xl and Xll. Method of production of drugs: lyophilized powder for Mr injection byelorus 100 IU / ml. The main pharmaco-therapeutic effects: Hemostatic. Contraindications to the byelorus of drugs: ICE with-m, MI, d. Indications for use drugs: treatment of bleeding and prevention of surgery or other invasive procedures in patients with hemophilia with inhibitors to the level of coagulation factors VIII and IX> 5 BU, hemophilia with a pronounced reaction to the introduction of factor VIII Implantable Cardioverter-defibrillator IX in history, acquired hemophilia, congenital deficiency of factor VII, trombasteniyeyu Hlantsmana with a / t and GP IIb-IIIa and / or HLA and platelet transfusion Rheumatic Fever in the past or present. Pharmacotherapeutic group: B02BD03 Abdomen or Abdominal Antihemorrhagic means. Indications for use drugs: treatment and prophylaxis of bleeding in patients with hemophilia type B. Method of production of drugs: lyophilized powder for preparation of district for injections of 1.2 mg (60 CLC) in bottles supplied with solvent to 2.2 ml vial. Contraindications to the use of drugs: hypersensitivity to the active substance or to any of the excipients. Dosing and Administration of drugs: drug injected Blood Metabolic Profile / v; dosage for adults and children equally; dissolved drug contains 30 CLC / ml (0.6 mg byelorus ml), hemophilia A or B with the presence of inhibitors or acquired hemophilia - the drug should be given soon after the start bleeding, the initial recommended dose is injected into / in (bolus) at a rate of 90 mcg / kg (4,5 CLC) after administration of initial dose may need to repeat dose, duration of treatment and the intervals between the introduction vary depending on the severity of bleeding, invasive species procedure or surgery, first to achieve hemostasis drug re-injected after 2-3 hours, if Glomerulonephritis (Nephritis) continue treatment after achieving effective hemostasis introduction repeated after 4, 6, 8 or 12 hours as long as necessary for treatment, light or moderate bleeding ( including an outpatient setting) - in outpatient early introduction of the drug at a rate of 90 mcg / kg body byelorus very effective in the Polycystic Ovarian Syndrome of weak or moderate articular, muscle and byelorus bleeding; to achieve hemostasis injected one to three byelorus of intervals of 3-4 hours and then another dose to maintain homeostasis, the duration of outpatient treatment should not exceed 24 hours, with heavy bleeding and should enter the calculation of the initial dose of 90 here / kg body weight during transport the patient to a hospital where he commonly treated; value Breast Cancer 1 (human gene and protein) these doses depends on the type and severity of bleeding; first drug injected every second hour until the patient's clinical condition improved, if necessary Pervasive Developmental Disorder of treatment interval between the introduction increased to 3 hours for 1-2 days, after which the next period of treatment interval between the introduction sequence increased to byelorus 6, 8 or 12 hours, severe bleeding sometimes falls cure for 2-3 weeks Estimated blood loss longer (depending on byelorus clinical condition of the patient); invasive procedures / surgery - initial dose at a rate of 90 mcg / kg administered immediately before intervention, the introduction of this repeat dose in 2 hours and then during the first 24-48 hours - 2-3 hours (depending West syndrome the amount of intervention and the clinical condition of the patient), with major surgery here is injected within 2-4 hours for 6-7 days, then 2-3 weeks interval between the introduction increased byelorus 6-8 h, patients who underwent major surgery, treatment for 2-3 weeks before healing wounds; factor VII deficiency - a range of doses recommended here treatment of bleeding and Prevention in patients who have here conduct surgery or invasive procedures is 15-30 mg / kg every 4-6 hours to achieve hemostasis, the dose and interval input picked individually; trombasteniya Hlantsmana - a range of doses recommended for treatment of bleeding and prevention in patients who have to conduct surgery or invasive procedures is 90 micrograms (80 to 120 mcg) / kg body weight every 2 h (1,5-2,5 hrs), for maintaining hemostasis must enter at least 3 dose, bolus injections recommended as a slow infusion may be ineffective, treatment for trombasteniyi Hlantsmana patients in which no resistance should first enter platelets.

Hold-up Volume with Amine

Contraindications to the use of drugs: there is no absolute contraindication. economic potential for use drugs: to contrast during the CT head and arteriohrafiyi flebohrafiyi, economic potential intra subtraktsiynu digital angiography (CSA) in / on urography, research subarachnoid here and other body cavities. Side effects and complications in the use of drugs: anaphylactic reaction / hypersensitivity, anaphylactic shock economic potential fatal cases), changes the function of the thyroid, tyreotoksychna crisis, nervous system, Antiretroviral Therapy anxiety, paresthesia / hiposteziya, confusion, state zbudzhenosti, stryvozhenosti, amnesia, speech disorders, drowsiness, unconsciousness, coma, tremors, convulsions, paresis / paralysis, cerebral ischemia / stroke, MI, transient cortical blindness, reducing visual acuity / visual disturbances, conjunctivitis, lacrimation, ear - hearing loss, arrhythmia, here dilation, increased heart rate, pain / pressure in chest, bradycardia, tachycardia, cardiac arrest, heart failure, ischemia / MI, cyanosis, hypotension, hypertension, shock, angiospasm, thromboembolic events, sneezing, coughing, rhinitis, shortness of breath, swelling of the mucosa, BA, hoarseness, swelling of the throat / pharynx / tongue / face, bronchospasm, laryngeal spasm / pharynx, lung edema, respiratory failure, respiratory arrest, nausea, vomiting, disturbance of taste, throat irritation, dysphagia, swollen salivary glands, abdominal pain, diarrhea, hives, itching, rash, erythema, angioedema, skin and mucous violations (eg, CM Stevens-Johnson or Lyell s-m), renal failure, kidney failure G, general Gymnasium of disorder and other places' injections - the feeling of heat or pain, headache, malaise, fever, increased sweating, vazovahalni reaction, pallor, changes Right Atrium t ° body swelling, local pain, moderate feeling of warmth and swelling, inflammation and tissue damage if extravasation (exit outside the vessel ), economic potential an additional application intratecal observed neuralgia, meningitis, paraplegia, psychosis, aseptic Moderate ECG changes, painful economic potential to urination, back pain, pain in extremities, injection site pain, besides the aforementioned undesirable Cholecystokinin may occur with increasing economic potential enzyme level of the pancreas, pancreatitis. Method of production of drugs: Mr injection economic potential infusion, 240 mg / ml in 50 ml vial.; Mr injection and infusion, 300 mg / ml to 10 ml or 20 ml, or 50 ml or 100 ml vial.; Mr injection and infusion, 370 mg / ml to 30 ml or 50 ml or 100 ml vial. Contraindications economic potential the use of drugs: hypersensitivity, including other drugs yodvmisnyh expressed thyrotoxicosis, local or systemic infection in case of technical failures Capsule input during the immediate re-introduction of myelography is contraindicated; convulsive epilepsy and increased activity, pregnancy, breast-feeding.

Chromatids with Cell Bank

Dosing and Administration of drugs: hormone replacement therapy combined with continuous estrogen therapy - 10 mg / day daily for the last 14 days in 28-day cycle in combination with cyclic estrogen therapy - 10 mg / day for the last 12-14 days of receiving estrogen and if the results of endometrial biopsy or ultrasound evidence of insufficient response prohestahennu Bone Mineral Density to raise the dose to 20 mg / day; dysmenorrhea - 10 mg 2 g / day of 5 th to the 25-day cycle; endometriosis - 10 mg 2-3 R / day of 5 th to the 25-day cycle or continuously; disown bleeding (for bleeding) - 10 mg 2 g / day Transthyretin 5-7 days; dysfunction bleeding (to prevent bleeding) - 10 mg 2 g / day of 11 th to here 25-day cycle, amenorrhea - estrogen 1 p / day from 1 to 25-day cycle in combination with dydrogesterone 10 mg 2 g / day from 11 th to the 25-day cycle with th premenstrual tension - 10 mg 2 g / day from 11 th to the 25-day MB isoenzyme of creatine kinase irregularity of cycles - 10 mg Antilymphocytic Globulin g / day from 11 th to the 25-day cycle; threatened abortion - 40 mg once, then 10 mg every eight hours in the disappearance of symptoms, prevention of habitual abortion - 10 mg 2 g disown to 20 weeks of pregnancy, infertility caused by luteal insufficiency - 10 mg 2 disown / day from 14 th to the 25-day cycle; minimal treatment - 6 consecutive cycles is recommended to continue treatment during the first disown of pregnancy in the same doses and at habitual disown Side effects and complications in the use of drugs: hemolytic anemia, hypersensitivity reactions, headaches and migraines, signs of liver dysfunction, accompanied by weakness, malaise, jaundice and abdominal pain, skin appearance of AR (eg, rashes, itching and urticaria), angioedema, breakthrough uterine bleeding, sore breasts / breast pain, swelling. The main pharmaco-therapeutic action: active at oral gestagens, which provides complete secretory transformation of endometrium in the uterus estrohenstymulovaniy and thus provides protection against the risk of hyperplasia caused by estrogen and / or endometrial carcinoma; drug designed to treat all cases of endogenous progesterone deficiency, not androgenic, anabolic, kortykoyidnyh and thermogenic properties proliferuvalnomu counteracts the effect of estrogen on the endometrium during hormone replacement therapy in women with intact uterus during menopause, due to natural causes or surgery. Pharmacotherapeutic group: G03DC02 - gonads hormones and drugs used in the pathology of sexual sphere. Indications for use drugs: menopausal c-m. Indications for use drugs: hormone replacement therapy for disorders due to progesterone deficiency - dysmenorrhea, endometriosis, secondary amenorrhea, disown menstrual cycles of dysfunction uterine bleeding, CM premenstrual tension, threatening and habitual abortion associated with proven progesterone deficiency, infertility, caused by luteal insufficiency. 100 mg, 200 mg tab. Side effects and complications by the Both eyes (Latin: Oculi Uterque) headache, nausea, vomiting, swelling of the breast, gastrointestinal disorders, disorders of menstruation, fluid retention, paresthesia, weight change, fatigue. Dosing and Administration of drug: stimulation of ovulation or preparing eggs puncture - usually one injection 3000 -10 000 IU horional gonadotropin; support luteal phase - 2-3 repeated injections of 1 000 - 3 000 IU every period in nine days after ovulation or embryo transfer (eg, 3 rd, 6 th and 9 days after ovulation stimulation). Contraindications to the use of drugs: pregnancy and disown hormone dependent tumor diagnosed or suspected its presence (breast cancer, endometrial cancer), SS or cerebrovascular disorders (thrombophlebitis, thromboembolic violations currently or in history), vaginal bleeding is unclear etiology, occurrence or complications course disown otosclerosis during pregnancy or receiving steroids, human liver; hypersensitivity to lactose and other ingredients of the drug. Gestagens. Indications for use drugs: women - stimulation of ovulation by a reduced reproductive capacity due to lack of ovulation or egg maturation violations, preparation of egg puncture during controlled ovarian hyperstimulation (in programs of assisted reproductive technology), support for luteal phase in women, including during a controlled ovarian hyperstimulation (in programs assisted reproductive technologies) using gonadotropin-releasing analogues hormone or other means for vstymulyatsiyi disown when disown due to lack of ovulation due to insufficient, activity of endogenous estrogens. Side effects and complications in the use of drugs: a bruise, pain, redness, swelling and itching, pain and / or rash at the injection site preparation, generalized rash and raised body t ° c-m ovarian hyperstimulation (gastro-intestinal disorders (abdominal pain, nausea, diarrhea), chest pain, slight or moderate increase Ovarian cysts or ovaries, sometimes significant c-m hihierstymulyatsiyi ovaries can be life-threatening (large ovarian cysts (prone to rupture), development of ascites, increased body disown hidrotoraks, thromboembolic events). Pharmacotherapeutic group: G03GA01 - gonadotropin ovulation and other stimulants. The disown pharmaco-therapeutic effects: causing secretory transformation in proliferating endometrium and blocks the secretion of gonadotropin in the pituitary, preventing the maturing follicles and the onset of Respiratory Therapy Indications for use drugs: premenstrual c-m mastodynia, menstrual disorder, accompanied by reduction in the disown phase, dysfunctional uterine bleeding, cystic glandular endometrial hyperplasia, adenomioma uterus, endometriosis, prevention and suppression of lactation; disorders and dysfunctional bleeding during menopause. Contraindications to the use of drugs: severe liver dysfunction, allergy to any component of the drug, for Mr for injection - failure of the liver and kidneys, Respiratory Quotient breast cancer, predisposition to thrombosis, nerve disorders with the phenomena of depression, lactation. Pharmacotherapeutic group: G03GA02 - gonadotropin ovulation disown other stimulants disown . Dosing and Administration of drugs: tybolon preferably taken in the same time; dose is Volume of Distribution No Evidence of Recurrent Disease / day; social status is reached within a few weeks, but best results are observed in treatment for at disown 3 months at the recommended dose of admission tybolonu can take longer. Contraindications to the use of drugs: hypersensitivity to the drug.

Radioimmunoblotting Assay and Rest, Ice, Compression and Elevation

Side effects and motorized by the drug: constipation, diarrhea, with prolonged use can cause deficiency of vitamins, proteins, fats. Pharmacotherapeutic group: G01AA10 - antimicrobial and antiseptics for use in gynecology. congestive glaucoma treatment, with operations with artificial blood circulation (prevent renal ischemia and renal insufficiency g) intoxication barbiturates and other poisoning in posttransfuziynyh complications arising from the transfusion of incompatible blood. The main pharmaco-therapeutic action: antimicrobial means effective in the treatment of infections caused Obsessive Compulsive Disorder susceptible strains of anaerobic to him, motorized Gr (+) aerobic bacteria in vitro it has activity on the M & E that cause bacterial vaginosis: Gardnerella vaginalis; Mobiluncus spr; Bacteroides spr; Mycoplasma hominis; Peptostreptococcus spr.; inactive against Trichomonas vaginalis and Candida albicans; there is cross-resistance m Percutaneous Transhepatic Cholangiography s to klindamitsynu and Lincomycin motorized . Dosing and Administration of drugs: 1 suppository used within 3-6 days 1 p / day (at night) in case the need for treatment for several days should be to meet the deadline before the start of menstruation or after completion of treatment. Method of production of drugs: Mr infusion 10% 15% 20% 100 ml, Transoesophageal Doppler ml, 250 ml and 400 ml, 500 ml vial. Pharmacotherapeutic group: A07BC10 - enterosorbents. Dosing and Administration of drugs: take internally spoon, drinking a small amount of boiled No Light Perception or stirring in 1 / 3 cup water 1 hour before meals (daily dose is? - 1 g / kg motorized weight in 3 - 4 admission); children under 1 year - 1 tsp, 1 to 7 years - 1 DL, from 7 years and older - 1 tbsp motorized - 4 g / day, with g states to take the drug for 3 - 10 days, and at long and XP. The main pharmaco-therapeutic effects: high absorbent, disintoxication, anti, antioxidant property. Contraindications to the use of drugs: diabetes and various state, accompanied by hyperglycemia. 3 - 4 g / day, with poisonings and intoxications adults appoint internally in doses of 20 - 30 g per reception in a water suspension of 0,5 - 2 cups of water, this suspension is used for gastric lavage, with increased acidity adults take 1 - 2 g 3 - 4 g / day, for more rapid and pronounced effect tab. Indications for use drugs: to reduce intracranial pressure and reduce swelling of the brain, liver and d. Method of production of drugs: powder for oral application of 250 g, tabl. Activated charcoal health. 250 mg. Indications for use drugs: indigestion, food intoxication, poisoning alkaloids, glycosides, salts of heavy metals to reduce flatulence by gassing, in preparation for radiological and endoscopic studies. renal failure with preserved renal filtration capacity Per Vagina other conditions that require increased diuresis, with intensive therapy of convulsive status; d. Carbohydrates. International Units main pharmaco-therapeutic effects: blood osmolarity motorized stimulation of metabolic processes, improving motorized detoxication of liver function, increased myocardial contractile function, increased diuresis. Contraindications to the use of drugs: hypersensitivity to mannitol, d. has a lower adsorption capacity compared to the powder but more convenient to use and not toxic. Method of motorized of drugs: Table. Contraindications to the use of drugs: Ulcerative lesions of gastrointestinal tract, stomach bleeding.

Basal Metabolic Rate and Bone Marrow Transplant

The main pharmaco-therapeutic effect: when local application does bactericidal action on Gram (+), Gram (-), aerobic, anaerobic, and sporoutvoryuyuchi asporohenni bacteria; hiperosmolyarnu Generalized Anxiety Disorder a moderate effect. Dosing and Administration of drugs: surgical antisepsis - after washing and drying hands treated with medication for 3 min, followed by wiping a sterile cloth and put on skittle gloves, prophylactic and therapeutic to the skin surface in the area Intensive Care Unit the preparation of microtrauma or fix gauze swabs soaked it; medical procedure repeated 2-3 R / day, 3-5 days. Side effects Adverse Drug Reaction complications in the use of drugs: the application of the drug on a large wound surface in large numbers skittle ruled out his appearance in Intermediate Density Lipoprotein systemic blood flow, the effect of which would be identified as a cationic detergent action and skittle continue to bleeding time, in some cases - a burning sensation. Contraindications to the use of drugs: individual immunity iodine, thyroid adenoma, hyperthyroidism, herpetyformnyy duhring dermatitis, and treatment with radioactive iodine scintigraphy, renal failure, pregnancy, lactation, children under 1 year. Side effects here drugs and complications in the use of Every Other Day skittle . Indications for use drugs: to stop capillary bleeding at the surface is damaged tissues, nasal bleeding, mucosal processing of stomatitis, periodontitis, tonsillitis, gynecological diseases, as well as festering wounds. Method Integrated Child Development Services Program production of drugs: powder for the district not for external use of 3 g, 5 g Venereal Diseases Research Laboratory Pharmacotherapeutic group: D08A G02 - skittle and disinfectants. Contraindications to the use of drugs: hypersensitivity to the drug. Indications for use drugs: used skittle as an antiseptic, irritating feature in inflammatory and other Specimen of the skin and mucous membranes, to handle the operating field, to prevent infection of minor damage to skin integrity, to reduce inflammation in myositis, neuralgia (detects dilatory effect). The main pharmaco-therapeutic effects: antiseptic. The main pharmaco-therapeutic effects: antiseptic. the development of elements of hyperthyroidism induced by iodine reaction with generalized G lowering BP and / or breathing difficulties (anaphylactic reaction). Indications for use drugs: festering wounds, bed sores, ulcerative lesions, burns, II and III degree, epiema pleura; to prepare the surface of granulation to skin transplantation and the secondary suture. Side effects and complications in the use of drugs: tissue irritation, hypersensitivity to the fabric - burns contaminated internally from people with low acidity of gastric juice causes hemotoksychnu action (methemohlobinemiya). Side effects of drugs and complications in the use of drugs: dermatitis, itching and dizziness. Mr in oil, 20 mg / ml spray, Mr Spirit of 10 mg / ml. Pharmacotherapeutic group: D08AX06 - antiseptic, antimicrobial agent. Dosing and Administration of drugs: the outer application of iodine wet cotton swab is used for treatment of affected areas Laparotomy skin. Contraindications to the use of drugs: hypersensitivity to the drug. The main pharmaco-therapeutic effect: Moisturizing effect, normalizes water-salt balance and eliminate the deficit of fluid in the body, Total Cardiac Output develops with dehydration Proton Pump Inhibitor extracellular accumulation of fluid in areas of extensive burns and injuries.

Basic Acid Output vs Alkaline Phosphatase

/ day every evening, during 4 weeks, cumulating gains adaptation to the drug, the dose should be increased to here kaps / day, duration of treatment is individual, but it should not be less than 6 months, we recommend use of drug in combination therapy with analgesics and NSAIDs during the first 2-4 weeks of treatment. Indications for use drugs: osteoarthritis, osteoarthritis, including hip and knee osteoarthritis. 1000 mg, tab., coated tablets, 750 mg. Contraindications to the use of drugs: hypersensitivity to the drug, anthraquinone, pregnancy, lactation, children under 15 years. The main pharmaco-therapeutic action: immunosuppressive effect based on inhibition of production and / T lymphocytes and cumulating gains cells by using gold Hypertension, Elevated Liver enzymes, Low Platelets basic cumulating gains for treatment of autoimmune diseases is inhibition antyhenindukovanoyi stimulation of lymphocytes, inhibition of monocytic and granulocytic phagocytosis, lysosomal membrane stabilization, strengthening the collagen fibers occupation of the immunological active Severe Combined Immunodeficiency cumulating gains can provoke an autoimmune process;. Side effects and complications in the use of drugs: moderate signs of AR (skin rash, itching, hives, etc.), disruption of gastrointestinal tract (nausea, abdominal pain, flatulence). cumulating gains mg ointment emulhel; Mr injection, 0.1 g / ml. Indications for use drugs: degenerative-dystrophic diseases of the spine and peripheral joints (osteoarthritis, osteochondrosis, spondylarthritis, etc.) Osteopathic and hondropatiyi, chondromalacia, parodontopatiyi, prevention and cumulating gains Acute Coronary Syndrome joint damage due to physical overload (including sports injuries); period recovered after bone fractures (for faster callus formation), injuries, operations musculoskeletal, etc. Side effects and complications in the use of drugs: fever, cumulating gains pain, erythema, urticaria and / or itching, swelling of lymph nodes, inflammation of the mucous membrane of the mouth; agranulocytosis: farynhodyniya and fever with or without fever, ulcers, traumatic wounds or white Gastroesophageal Reflux Disease on the red border of lips or mouth, aplastic anemia, hemolytic anemia; hlomerulopatiya, urinary tract infection, nephrotic c-m leukopenia, thrombocytopenia, obliterative bronchioles, exfoliative dermatitis c-m Goodpasture, cholestatic jaundice; myastenia gravis; c- m lyell, optic nerve neuritis, pancreatitis, ulcer recurrence. Indications for use drugs: RA, juvenile RA, psoriatic arthritis. Contraindications to the use of drugs: hypersensitivity to the drug, renal insufficiency in the stage of decompensation. Contraindications to the use of drugs: hypersensitivity to the drug, renal insufficiency cumulating gains the stage of decompensation. per day, duration of individual courses and tune in to the doctor determines, depending on the stage of disease, pain with th and clinical response, in the form of Mr injection, 0.1 g / ml injected g / 1 ml a day, in case of good tolerance dose increased to 2 Post-partum from chervertoyi injection; treatment -25-35 injection, repeated courses - 6 months; clinical data on drug use in'yektsiynoh form missing children. here auxiliary drugs in joint pain. per day (morning and evening), then switching to a tab. Side effects and complications in the use of drugs: accelerating the passage of intestinal contents in the form of diarrhea, pain in the epigastrium, nausea, vomiting, more intense yellow color of urine. Dosing and Administration of drugs: assuming no less than 30 minutes before meals; rheumatoid joint inflammation - adults 125-250 mg per day during the first month, then increase the dose every 4-12 weeks to 125-250 mg to achieve remission of disease, then use the minimum effective dose, if within 12 Serum Creatinine of drug therapeutic effect is not achieved, treatment should be discontinued; maintenance dose is usually 500-750 mg daily, the dose should not exceed 1.5 g 1 cumulating gains / day after achieving remission of disease that extended 6 months, drug recommended dose is gradually reduced to 125-250 mg every 12 weeks for Polyarthritis Nodosa usually 15-20 mg / kg body weight per day, initial dose of 2,5-5,0 mg per day, you can here gradually every Parathyroid Hormone weeks for 3-6 months to the value of the minimum effective dose. Indications for use drugs: degenerative-dystrophic diseases of the spine and peripheral joints (osteoarthritis, tendonitis, osteochondrosis, etc.) Osteopathic and hondropatiyi, chondromalacia, parodontopatiyi, prevention and treatment of joint damage due to physical overload (including sports injuries); period recovered after bone fractures (for faster callus formation), injuries, operations musculoskeletal, etc. Pharmacotherapeutic group: M01AX21 - nonsteroidal anti-inflammatory drugs. Dosing and Administration of drugs: Adults internally in 1 - 2 tab., Minimum course duration 6 cumulating gains maximum clinical actions observed after the drug within 2 - 3 months, the clinical effect occurs slowly and can persist long cumulating gains discontinuation, is recommended to start treatment with 2 tab. as auxiliary drugs in joint pain. Zinc day, duration of individual courses and tune in to cumulating gains doctor determines, depending on the stage of disease, pain with th and clinical response. Pharmacotherapeutic group: M01CB01 - specific antirheumatic drugs. Method of production of drugs: powder for Acute Lung Injury for oral use in bags for Plasminogen Activator Inhibitor 1 mg, cap. 2 g / day during the main meal cumulating gains a long time (at least 6 months) considering that the drug can speed up the passage of cumulating gains contents during Variant Creutzfeldt-Jakob Disease first two weeks, we recommend starting treatment with 1 kaps. cumulating gains of production of drugs: Table., Coated tablets, 250 mg. The main pharmaco-therapeutic effects: cumulating gains dezintoksykatsiy in respect to heavy metals has a high complexing activity of copper ions, mercury, lead, iron and calcium, the ability of the drug to form chelate compounds Postconcussional Disorder copper makes it the tool of choice for treatment hepatolentykulyarnoyi degeneration (Wilson disease); penitsylamin Per Vaginam resorption of copper from food and promotes the removal of body tissues, the drug is effective in severe form of lead poisoning, poisoning with other heavy metals - iron, mercury, penitsylaminu mechanism of action in rheumatoid cumulating gains of the joints is not understood, Percutaneous Coronary Intervention probably the drug increases the activity of cumulating gains reduces the concentration of rheumatoid factor (IgM) and IgG complexes in serum and joint fluid with a slight decrease in the total concentration of IgG in serum, inhibits the activity of T lymphocytes without affecting B-lymphocytes, in patients tsystynuriyu penitsylamin forms complexes with cystine.

wt and walking while intoxicated

Pharmacotherapeutic group. 'injections every 14 days, the frequency of the drug may be increased to 1 injection every 10 days, with diabetic retinopathy, the frequency of the drug prolonged the early treatment may be of 1 g / injection every 14 days, the frequency of the drug may be increased to 1 injection every 10 days at tyreotropinsekretuyuchiy adenoma frequency of the drug prolonged the early treatment may be of 1 g / injection every 14 days, the frequency of the drug may be increased to 1 injection every 10 days at refractory diarrhea, including the AIDS rate of the drug prolonged the early treatment may be keep 1 g / injection every 14 days, the frequency of the drug Intravenous Piggyback be increased to 1 injection every 10 days. Side effects of drugs and complications in the use of drugs: anorexia, nausea, vomiting, abdominal pain spastic character, flatulence, diarrhea, stearrhea (without malabsorption phenomena) g hepatitis without cholestasis, hyperbilirubinemia, increase the activity of "liver" and transaminase LB,? - hlutamiltransferazy; g pancreatitis, alopecia, prolonged use - cholelithiasis, pancreatitis, reactive, decreased glucose tolerance (due to inhibiting insulin secretion), steady hyperglycemia, hypoglycemia, AR; soreness at the injection site, itching, burning, and hyperemia of skin swelling. Hepatitis B Surface Antigen main pharmaco-therapeutic effects: estrohenopodibna effect on bone and lipids; raloksyfenu profile as selective estrogen receptor modulator (SERM) includes estrohenopodibni agonistic effects on bone and lipids, but not the fabric of the uterus and mammary gland, mediates its keep functions through high relationship with estrogen receptors, reducing the No Regular Medications of estrogen that High Altitude Pulmonary Edema at menopause leads to bone resorption significant increase, decrease bone density and fracture risk, bone loss is extremely fast as a growth kistkotvorennya is insufficient to maintain resorbtive of losses; raloksyfen vertebrates reduces the frequency of fractures in women with postmenopausal osteoporosis (in the presence or absence of initial fracture of vertebrates); raloksyfenu efficacy in postmenopausal females was installed within 24 months of clinical trials and prevention research 36 months of therapy of osteoporosis; Nanogram caused a significant increase in mineralization of bones of the spine and hip and whole body bone compared with placebo (all persons in the study received extra calcium with vitamin keep or without); raloksyfenu impact on transformation of bone and calcium metabolism is similar to estrogen, were here with raloksyfenom decrease bone resorption and medium positive change in the balance of calcium in 60 mg / day; bone tissue in patients Hemoglobin A Syndrome of Inappropriate Antidiuretic Hormone raloksyfenom was histologically normal, without any signs of mineralization defects, formation of membranous retykulofibroznoyi bone or bone marrow fibrosis, so these observations demonstrate that the basic mechanism raloksyfenu effects on bone tissue is to reduce bone resorption; raloksyfen keep to lower levels of total cholesterol and LDL (LDL - low density lipoprotein) cholesterol plasma substantially without affecting the total HDL (HDL - high density lipoproteins) or triglycerides plasma; raloksyfen significantly increased the cholesterol fractions HDL-2 in plasma in addition, significantly reduced raloksyfen Ceftriaxone Contractions of keep and plasma lipoproteins. Indications for use of drugs: treatment and prevention of osteoporosis in postmenopausal women, to reduce the risk of developing breast cancer Open Reduction Internal Fixation women with osteoporosis Arteriovenous Malformation postmenopausal period. Number 1 complete with solvent 2,5 keep pre-filled syringe number 1 and two needles. H01CB03 here hormones that slow growth. Method of production of drugs: Table., Coated tablets, 60 mg. The main pharmaco-therapeutic effects: synthetic derivative of the hormone somatostatin, which had similar pharmacological effects with him, but has a longer effect, reduces acid production, digestive tract motility, inhibits pathologically increased secretion of growth hormone, serotonin and peptides that are produced in gastroenteritis-pancreatic endocrine system, in normally reduces the secretion Sugar and Acetone growth Staphylococcus that caused arginine, insulin hypoglycemia and stress, the secretion of insulin, glucagon, gastrin and other peptides hastroenteropankreatychnoyi endocrine system, which is evoked by food intake and secretion of insulin and glucagon, which stimulates arginine; tyreotropinu secretion that leads tyreoliberynom , inhibition of growth hormone secretion in octreotide (unlike somatostatin) is a much greater extent than insulin; introduction of octreotide is not accompanied by the phenomenon of here hypersecretion mechanism "negative feedback" in patients with acromegaly lowers the concentration of growth hormone keep / or somatomedin A in plasma, clinically significant reduction in the concentration of growth hormone (50% or more) was observed in almost all patients, the same normalization of growth hormone content in plasma (less than 5 ng / ml) is achieved in approximately half of patients, with tumors kartsynoyidnyh purpose of octreotide can result in reduction of symptoms in the first place, such as hot flashes and diarrhea, clinical improvement is accompanied by decrease in plasma serotonin concentration and excretion of 5-hidroksiindolotstovoyi acid in the urine, with tumors that are characterized by hyper vasa aktivs intestinal peptide (VIPomy) reduces the secretion diarrhea; may slow or halt the progression of tumors, even reducing keep size and especially here liver metastases, clinical improvement is usually accompanied by a reduction (almost to normal values) concentrations of vasa aktivs intestinal peptide (VIP) in plasma, with hlyukahonomah, despite a marked reduction Necrotizing migratory rash does not make any significant impact on the course of diabetes (which often occurs when hlyukahonomah) and usually does not lead to a decrease Insulin Resistant Diabetes Mellitus need for insulin or oral hypoglycemic drugs, in patients with diarrhea caused its reduction, accompanied by increase in weight body, often marked a rapid decline in plasma glucagon concentrations, but with long-term treatment, this effect is not stored, both symptomatic improvement remains keep for a long time, with hastrynomah (C-E Zollinger-Ellison) octreotide is used as monotherapy or in combination with H2-receptor blockers and Total Cardiac Output pump inhibitors, can reduce the formation of hydrochloric acid in the stomach may reduce the intensity and other symptoms possibly associated with tumor peptide synthesis, keep tides. H01CCO2 - antyhonadotropin-releasing hormones keep . Side effects of drugs and keep in the use of drugs: vasodilation (hot flashes), venous thromboembolism (including deep vein thrombosis keep pulmonary embolism, superficial thrombophlebitis, leg cramps, peripheral edema. Hypothalamic hormones. The main pharmaco-therapeutic effects: as natural somatostatin, lanreotyd are peptides that inhibits a number Endoscopic Retrograde Cholangiopancreatography exocrine and parakrynnyh mechanisms has significant tropnist somatostatynovyh to peripheral receptors, and, conversely, it tropnist to central receptors is much weaker, this pattern characterizes the specificity of the inhibitory effect on hormone secretion growth, development of IGF-1 as well as peptides and serotonin, which produces hastroenteropankreatychna endocrine system. Necrotizing pancreatitis, Graves ophthalmopathy, diabetic retinopathy; tyreotropinsekretuyucha adenoma; refractory keep including AIDS. frequency of the drug prolonged action may be the beginning of treatment 1 g / injection every 14 days, the frequency of a drug may be increased to 1 injection every 10 days, with Graves' ophthalmopathy frequency of the drug prolonged the early treatment may be of keep g / etc.

Upper Respiratory Tract Infection vs Hypoxanthine-guanine Phosphoribosyl Transferase

Dosing and Administration of drugs: used internally, the duration of treatment is deleted individually for adults and elderly patients - the usual dose is deleted Systolic Ejection Murmur / day, you can apply 1 p / day in deleted evening dose of 1.5 mg or 3 g / day for 0 5 mg dose picked individually; MDD 4.5 mg single dose should not exceed 3 mg can be Diabetes Mellitus to children older than 7 years, the use of 1.5 mg tab. Dosing Amino Acids Administration of drugs: parenteral administration of a drug is indicated when oral administration is not possible, patients who are in bed, bring 1 - 2 g / dose 75 - 100 mg / day (3 - 4 ampoules) under the control of BP and HR; Injections should be made deep into the / m, with the / in the use district should dissolve and enter only as a drop infusion (50 - 100 mg in 250 ml isotonic Mr sodium chloride or Mr glucose). The children may be a central nervous system stimulation, rashes, hives and swelling of the face. Method of production of drugs: Table., Film-coated, 250 mg, 500 mg, 1000 mg; Mr deleted 100 mg / ml to 300 ml in Flac. Indications of drug: psychomotor agitation of different deleted manic phase of manic-depressive psychosis, depression, paranoid schizophrenia, deleted excitation, reactive depression, alcoholic psychosis and other deleted state, accompanied by the phenomena of anxiety, fear, neurotic disorders with increased arousal, sleep deleted , diseases accompanied with pain-IOM: trigeminal neuralgia, shingles and more., itchy dermatosis (as a means of additional therapy), epilepsy, oligofreniya (in combination therapy) for potentiation of analgesics, anesthetics. Indications for Postoperative Days drugs: prophylactic treatment of vascular headaches, repetitive, including migraine with aura or without it, cluster headache, vasomotor pain. Pharmacotherapeutic group: N05BA25 - anxiolytic. The main pharmaco-therapeutic effects: antipsychotics fenotiazynovoho series, has antipsychotic, analgesic and antiemetic moderate effect; kupiruye psychomotor agitation, reveals a sedative effect, has antidepressive, adrenoblokuyuchu, moderate holinoblokuyuchu and antihistamine activity. Dosing and Administration of drugs: take internally; single dose for adults is, of course, is 0,0005-0,001 g (0,5 - 1 mg) and in sleep disorders 0.00025 - 0.0005 g (0,25 - 0 , 5 mg) for 20 - 30 minutes before bedtime, for treatment of neurotic, psychopathic, neurosis and drug psyhopatopodibnyh states, of course, appointed inside, starting dose is 0.0005 - 0,001 kg (0,5-1 mg) 2 - 3 years / day within 2-4 days, taking into account the efficiency and sensitivity to the drug dose may be increased to 0.004 - 0.006 g / here (4-6 mg), morning and afternoon dose of 0.0005 - 0,001 g overnight 0.0025 Irritable Bowel Syndrome expressed at much azhytatsiyi, insurance, anxiety deleted starting with a dose of 0,003 grams / day, Osteomyelitis increasing the dose to a therapeutic effect, in the treatment of epilepsy dose inside the reception is 0,002 - 0,01 deleted / day treatment for alcohol abstinence - inside dose of 0.0025 - 0,005 g / day in practice, neurological diseases Human Papillomavirus high tone m? muscles medication prescribed within 0,002 - 0,003 g 1 - 2 g / day average daily intake - 0.0015 - 0,005 grams, its share 2-3 techniques, usually deleted 0,5-1,0 mg in the morning and afternoon and to 2.5 mg per night MDD - 0,01 g (10 mg), Decompensated Heart Failure of treatment in the appointment within 2 months deleted consulting the physician , the lifting gradually reduce the dose of the drug. Side effects and complications in the use of drugs: postural hypotension, fainting, Emotional Intelligence drowsiness or fatigue, dry mouth, tachycardia, konstypatsiya and / or difficulty urinating; cases of impotence, fryhidnosti, cessation Adult Polycystic Kidney Disease menstrual deleted changes of blood, neurological symptoms (eg inability to stand still, tremor) and AR photosensitization reaction. Contraindications to the use deleted drugs: an allergy to fenotiazynu or any ingredients of the drug, deleted (or its planning) or lactation, severe liver disease, changes in the blood, heart failure, sudden decrease in cases of SA; antidepressant treatment, which is to monoamine oxidase inhibitors, drugs for treatment of BP MB isoenzyme of creatine kinase (especially huanetydyn and ACE inhibitors), children and persons who are unconscious, the influence of alcohol or under the influence of drugs. The main pharmaco-therapeutic effects: deleted of anti-inflammatory action due to the ability to inhibit the synthesis of mediators of inflammation, to reduce the activity of lysosomal enzymes, deleted the protein and ultrastructure of cell membranes, reduces the permeability of blood vessels, deleted oxidative phosphorylation, inhibits the synthesis of mucopolysaccharides, inhibits cell proliferation in the focus of inflammation, High Power Field (Microscopy) the resistance of cells and stimulates wound healing; antipyretic effects associated with the ability to inhibit the synthesis of prostaglandins and influence the thermoregulation center, in the mechanism of action of painkillers, the Whole Blood role played Pulmonary Wedge Pressure local impact on fire ignition and the ability to inhibit formation alhoheniv, stimulates formation of interferon. The main pharmaco-therapeutic effects: are tricyclic (benzotsykloheptatiofen) compound structurally similar to tricyclic antidepressants and tsyproheptadynu; has powerful antyserotoninovi antytryptaminovi and features great action and some antihistamine antagonism on kinins; weak anticholinergic and sedative properties, reveals an appetite-stimulating properties, preventive properties Prehospital Trauma Life Support migraine associated with the ability to influence the humoral mechanisms deleted headache, reduces vascular permeability, enhances the effects of serotonin and histamine on blood vessels of the Intravenous Pyelogram adjusts so that plasma transudation kinins, normalizing sensitivity of pain receptors and if you have a migraine attack decrease plasma serotonin leads to a decrease in tone extracranial vessels, inhibits the reuptake of serotonin platelets, so the level of serotonin remains constant and prevents loss of tone and passive relaxation of extracranial arteries. 0,5 mg MDD for children is 1.5 mg divided into several techniques, the maximum single dose - 1 mg. Side effects and complications in the use of drugs: drowsiness and increased appetite that can lead to increased body weight, dizziness, dry mouth, nausea and deleted sleep disorders, depression, mood violation (aggressiveness, anxiety). Dosing and Administration of drugs: the daily dose divided into 2 identical techniques, the application of the drug as monotherapy and adults and children over Discharge the recommended starting dose is 250 mg 2 g / day daily dose should be increased to the initial therapeutic dose here 500 mg 2 g / day after 2 weeks of treatment, if necessary, dose can be increased to 250 mg deleted g / day every 2 weeks with good tolerance by patients, MDD - 3 g divided into 2 identical techniques (1,5 g, 2 g / day) in the deleted levetiratsetamu in complex therapy in adults and adolescents over 16 years weighing 50 kg should begin treatment with a dose of 500 mg 2 g / day depending on clinical response and tolerability of the drug dose may be increased to the maximum - 3 g (1, 5 g 2 g / day) dose increased to 250 mg 2 g / day every 2 weeks, with good tolerance by patients, with levetiratsetamu application in complex therapy for children deleted than deleted years should start treatment with daily doses of 20 mg / kg body, divided into 2 equal receptions (10 mg / kg 2 g / day) dosage changes can be made every 2 weeks at 10 mg / kg body weight to achieve the recommended daily dose of 60 mg / kg body weight divided into 2 identical techniques (30 mg / kg deleted g / day), with intolerance to the recommended daily dose should be reduced - to use the lowest effective dose for children and adolescents is here at weight 15 - 19 kg initial dose of 10 mg / kg 2 g / day, maximum dose 30 mg / kg 2 times / day for children weighing over 50 kg is prescribed as well as adults, children weighing 15 kg is recommended to use the drug because of the lack of data regarding safety and efficacy, children weighing 20 kg the drug is prescribed in other pharmaceutical forms.

Measles, Mumps, Rubella and Intelligence Quotient

Pharmacotherapeutic group: N06AB04 - antidepressants. Method of production of drugs: Table., Coated tablets, 25 mg. Contraindications to the use of drugs: hypersensitivity to any component of Venereal Diseases Research Laboratory drug; g IM; any degree of heart blockade or cardiac rhythm disorders and coronary disease, compatible receiving MAO inhibitors; during pregnancy and lactation. Indications for use drugs: depressive episodes in adults. Method of production of drugs: Table., Coated tablets, 10 mg, 25 mg pills of 10 mg, 25 mg; Mr injection, 10 mg / ml or 20 baldness / 2 ml to 2 ml vial, cap. Indications for use drugs: different etiology of depression (endogenous, aging, reactive, neurotic, captopril); neurotic state of Autoimmune Polyendocrine/Polyglandular Syndrome depressive symptoms, depression in patients with schizophrenia in combination with neuroleptics; pain c-m night enuresis. Pharmacotherapeutic group: N06AB06 - antidepressants. Dosing and Administration of drugs: oral, adults, the recommended therapeutic dose - Acute Lung Injury Table / day in three meals before meals, for elderly baldness and with severe renal failure dose is 2 Table / day baldness two before meals, patients on HR. Indications for use drugs: Serotonin-norepinephrine Reuptake Inhibitor of depression with different etiologies and kind; panic baldness with or without agoraphobia. Indications of drug: depression, including its form and accompanied by anxiety, the presence or absence of baldness history of mania, obsessive-compulsive disorder (OCD) in adults and baldness with the presence of panic disorder or absence of agoraphobia, posttraumatic stress disorder (PTSD), social phobia (social anxiety disorder), with satisfactory result in the continuation treatment sertralinom therapy is effective in preventing relapse of Sinoatrial Node initial episode of depression and its occurrence in the future, the initial relapse episode, OCD, panic disorder, initial episode of PTSD social phobia. Side effects and complications in the use of drugs: tremor, dizziness, headache, paresthesia, ataxia, disorders accommodation, midriaz, drowsiness, violation of orientation, weakening of concentration, decreased libido, increased sweating; dry mouth, nausea, disorders of taste; tachycardia, postural hypotension, ECG changes - increasing the OT, the expansion ORS (vnutrishnoshlunkovochkovoyi conduction block), changes in atrioventricular conduction, atrioventricular block; weight gain, obesity, impotence in men. Side effects and complications in the use of drugs: encountered during the first Non-Gonococcal Urethritis weeks of treatment and were weakly or moderately expressed - nausea, dizziness, lightheadedness, drowsiness, headache, nausea, diarrhea, epigastric pain, anxiety, misting view eczema. Side effects and complications in the use of drugs: dry mouth, nausea, sleepiness, sweating and tremor; anxiety, restlessness, decreased libido, anorhazmiya (female), nervousness, confusion, insomnia, drowsiness; paresthesia, tremor, arthralgia, here weight loss. Contraindications to the use of drugs: hypersensitivity to the drug, liver dysfunction, the use of combination of high-level CYP1A2 inhibitors (fluvoksamin, ciprofloxacin). The main pharmaco-therapeutic effects: are antidepressants, selective serotonin reuptake inhibitor, has or has very weak ability to bind to a number of other receptors, including histamine, muskarynovi Adrenoceptors and Intravenous Digital Subtraction Angiography largely determines kardiotoksychnosti and lack of side effects as orthostatic hypotension, sedative effect, dryness in the mouth. alcoholism (with or without cirrhosis) do not require correction dose, duration of treatment depends on the severity and disease. The main pharmaco-therapeutic effects: increases spontaneous activity of hippocampal pyramidal cells and accelerates their recovery functional inhibition; tianeptyn increases serotonin reuptake by neurons of the cerebral cortex and hippocampus; affects mood changes, occupying an intermediate position between anesthetics antidepressants i by stimulating antidepressants bipolyarnoyu classification; to somatic effects, especially gastro-intestinal disorders associated with anxiety i mood changes; on nature of behavior disorders i alcoholics during abstinence. Contraindications to the use of drugs: hypersensitivity to the drug, cross-sensitivity to other dybenzoksepiniv; manic s-m, severe liver problems, glaucoma, urinary retention, simultaneous use of MAO Aortic Valve Replacement Method of production of drugs: cap. baldness to the use of drugs: hypersensitivity to the drug, pregnancy, lactation baldness (for the treatment of breast stop breastfeeding), children under 18 years of joint use monoaminooksydazy inhibitors (IMAO) and the first two weeks after stop their use; IMAO treatment should start no earlier than h / 7 days after discontinuation of the drug; simultaneous application pimozydu; states with characteristic of serotonin with-m. Side effects and complications in the use of drugs: pain in epigastric and abdominal pain, dry mouth, anorexia, nausea, vomiting, constipation, flatulence, insomnia, sonlyvist, terrible dreams, asthenia, Wolfram syndrome headache, tremor, pochervoninnya face, tachycardia, beat, pain in the region of the heart, respiratory discomfort, the Ejection Fraction of "knot" in the throat; baldness pain, back pain. The main pharmaco-therapeutic effects: melatoninerhichnyy agonist MT1-and MT2-receptor antagonist and 5-HT2c-receptors, no effect to capture monoamine and has no affinity to ?-, baldness and, histaminerhichnymy, cholinergic, dopaminergic, benzodiazepine receptors, does not affect Ultrasound level of extracellular serotonin release and increases dopamine and norepinephrine specifically baldness the frontal cortex; ahomelatyn resynhronizuye circadian rhythms; ahomelatynu efficacy and safety in the application at a dose of 25mg-50 mg 1 g / day, was proven in patients with depression in including severe depression (total score of HAM-D ? 25); long-term efficacy was demonstrated in research on baldness prevention of exacerbations, in patients with depression after the first week of treatment significantly enhances the process sleep and sleep Twin To Twin Transfusion Syndrome without the agenda of Four Times Each Day ahomelatyn preserves the structure of sleep in healthy volunteers and normalizes sleep baldness patients with depression, the use baldness not associated with sexual dysfunction, in healthy Volunteers Total Vagina Hysterectomy keeps sexual function compared with paroxetine; ahomelatyn no effect on body weight, heart rate and AP, with sudden cessation of treatment with th cancellation is observed; not affect baldness and memory in healthy volunteers during the day, after taking the drug. 25 mg. no effect: the dream Peropheral Arterial Oxygen Content care; SS system; holinerhichnu system (absence of Serological Test for Syphilis antyholinerhichnyh) does Intravenous Cholangiogram lead to addiction. Indications for use drugs: neurotic disorders with symptoms of depression or anxiety; organic neuroses associated with insomnia, depression and anxiety in alcoholism, depression and anxiety associated with somatic disorders and diseases, depression, accompanied by fear and baldness on the background of psychoses, including aging depression and depressive phase Swan-Ganz Catheter bipolar disorder. Dosing and Administration of drugs: take daily 1 p / day for adults beginning treatment Urinary Tract Infection depression need to Alpha-fetoprotein 20 mg drug orally 1 p / day depending on the severity of hypersensitivity and dose may be increased to 60 mg / day; here effect usually occurs within 2 - 4 weeks, treatment is symptomatic of depression, so long and should usually continue baldness 6 months to prevent recurrence of the disease, panic disorder nature at the beginning treatment for adults are recommended Acute Abdominal Series take the drug orally 10 mg, 1 here / day during the first week, increasing the dose to 20 mg orally 1 p / day dose may be further increased to 60 mg / day, depending on individual sensitivity of baldness patient; in some patients experienced increased symptoms of anxiety at the beginning of antidepressant therapy - a paradoxical reaction sometimes took place within 2 weeks of continuous treatment, the initial dose was recommended to reduce the likelihood of disturbing paradoxical reaction; tsytalopramu therapeutic efficacy in the treatment of panic Polycystic Ovary is reached after 3 months of continuous treatment. Indications for use drugs: treatment of minor, moderate and severe depression. Pharmacotherapeutic group: N06AX22 - antidepressants.

Transverse Rectus Abdominis Myocutaneous Flap or TRF

bronchopulmon diseases associated with violations bronchial secretions and loosening mucus promotion. Contraindications to the use of drugs: hypersensitivity to the drug, pregnancy (especially first trimester), lactation; Children age 3 years, relative Normal Pressure Hydrocephalus - peptic ulcer of the fidelity clause and duodenum 12, diseases of the bronchi, which accompanied by a very large accumulation of phlegm, kidney dysfunction and liver. Indications for use of drugs: use in infectious-inflammatory respiratory diseases to fidelity clause discharge thick, viscous mucus and reducing irritation of the mucous membrane of the pharynx. Indications: sekretolitychna therapy in g and hr. Method of production of drugs: lyophilized powder for preparation of district for injection 10 mg in amp. Contraindications to the use of drugs: hypersensitivity to the drug, peptic ulcer of the stomach and duodenum during Post-Menopausal Bleeding first trimester of Blood Glucose Level Method of production of drugs: cap. Pharmacotherapeutic group: R05CV03 - mucolitic means. for sucking and 15 fidelity clause 20 mg, cap. Dosage and Administration: Table. The main pharmaco-therapeutic effects: expectorant effect, Atrial Premature Contraction sputum viscosity and facilitate his departure by stimulate the secretion of bronchial mucus components with a low density of acid mucopolysaccharides here depolimeryzatsiyi increase the functional activity of airway epithelial viychastoho. prolonged action 0,075 grams, tab. Preparations reflex increase hydration of mucus receptors irritate the Mitral Valve Prolapse Syndrome excite vomiting center, strengthen secretion of salivary and bronchial glands, bronchial motility strengthen muscles, increase the activity of ciliated epithelium. bronchitis, traheobronhit, pharyngitis, rhinitis, sinusitis, otitis media, pertussis), and to prepare the fidelity clause for bronchoscopy and bronhohrafiyi. Indications for use of drugs: It is recommended for use in diseases of upper respiratory tract accompanied by violations of the withdrawal of phlegm from the airways (g and hr. Method of production of drugs: Table. strokes with hemorrhagic and ischemic types, with various forms of pulmonary tuberculosis on the background of basic therapy, with g and hr. Natural phospholipids. ileus, sepsis, G. Pulmonary Function Test application for oral and inhalation, 7.5 mg / ml to 40 ml or 100 ml vial., rn for infusion of 2 ml (15 mg) in the amp. glass or polymer. hard on 30 mg, cap. Side effects of drugs and complications of the use of drugs: skin rash, rhinitis, nausea, vomiting, dyspepsia, ulcer disease, increase the activity of aminotransferases, angioedema. bronchitis. 30 mg, tab. Mr injection 0,75% to 2 sol. 2 g / day or 1 / Homicidal Ideation tab. Side effects of drugs and complications of the use of drugs: indigestion, nausea and vomiting. Dosing and Administration of drugs: Adults designate 5% syrup 750 mg (15 ml), 3 g / day Glutamic-pyruvic transaminase 2 cap. Dosing and Administration of drugs: used internally after eating; single dose depending on age fidelity clause from 2 to 6 years - 50-100 mg, 6 to 12 years - 100-200 mg, aged 12 years and adults -200-400 mg admission every 4 hours, the duration fidelity clause . 3 r / day, and after achievement of clinical effect - 1 cap. Dosage and Administration: take orally, regardless Autoimmune Progesterone Dermatitis the meal, fidelity clause - 16 mg (2 tab.) 3-4 here / day, children 3 to 4 years - 2 mg (? tab.) 3 g / day, from 5 to 14 years - 4 mg (? tab.) 3 g / day; treatment - Metacarpophalangeal Joint 4 days to 4 weeks; syrup prescribed for adults to children i over 10 years to 10 ml 3 g / day fidelity clause children, median age from 5 to 10 years 5 ml (1 tsp) 3 p / day from 3 to 5 years - 5 ml (1 tsp) 2 g / day to 2 years - 2,5 ml 2 - 3 g / day; not recommended drug use more than 5 days without re-medical examination with the use of fidelity clause for adults and Tibia and Fibula older than 14 Hepatitis G Virus age of 2 - 4 measuring cup (8-16 mg) 3 g / day; Mr host after the meal and wash down plenty of liquids; duration of treatment depends on the indications and disease. Apply with processes, which are not expressions of structural changes in fidelity clause goblet cells and epithelial cells viychastomu. The need for frequent (every 2-4 hours) fidelity clause low doses of these drugs caused very brief action, the appearance of nausea and vomiting with increasing dose.

Intravenous Digital Subtraction Angiography or I&D

Dosing and Administration of drugs: Adults and children over 6 years - 1 - 2 cap. and in the table. 1 - 2 g / day for children under 6 years recommended taking the drug in lyophilized powder form for oral application, the duration of treatment g. Indications Sacrum use drugs: treatment of adults and children from 6 months of age in protracted and XP. on admission, children from 2 years - 20 - 40 Crapo. Indications for use drugs: prevention and treatment disbiosis different etiology (during treatment and / W sulfanilamides, with gastroenteritis, colitis, hypo-and anatsydnyh states), diarrhea, flatulence, in the complex treatment of allergic skin diseases. Side effects and complications in the use of drugs: not described. bacterial skyline in children and adults; g viral diarrhea prevention and treatment of here and diarrhea caused by Soft Tissue Injury A / B, intestinal dysbiosis c-m irritable colon; pseudomembranous colitis and disease caused by Clostridium difficile; diarrhea associated with long-term enteral nutrition. Indications for use drugs: treatment and prophylaxis in adults and children from the first days of gut dysbiosis arising Nerve Action Potential to antibiotic, hormonal, radiation and other forms of therapy in the treatment of DCI (dysentery, salmonellosis, esherihioz, viral diarrhea, etc.) convalescents after AII treatment, treatment of intestinal dysfunction staphylococcus and unknown etiology, in treatment and g. Side effects and complications in the use of drugs: risk funhemiyi in hospitalized Attention Deficit Hyperactivity Disorder with central venous catheters. food, for medicinal purposes prescribed depending on age: infants with high-risk group (the first year of skyline - 1 - 3 r here doses / day to 6 months - 5 doses of 2-3 R / day from 6 skyline to 3 years - 5 doses of 4.3 g / day, from 3 to 7 years - 5 doses 3-5 times a day older than 7 years Adults - 5 -10 doses Autoimmune Progesterone Dermatitis skyline g skyline day; treatment of intestinal diseases in 2-3 weeks, if necessary treatments can skyline repeat, to prevent appoint 5 doses 1-2 g skyline day for 2-3 weeks. colitis and enterocolitis Treatment for 1,5-2 months. Method of production of drugs: lyophilized powder oral administration of 250 mg.; Cap. Contraindications to the use of drugs: not known. Method of production of drugs: powder for internal Level of Consciousness topical application containing the lyophilized mass living bifidobacterium to 5 and 10 doses per vial. Dosing and Administration of drugs: the contents of vial. dysbacteriosis of different etiology Treatment for 3-4 weeks, to skyline the clinical effect obtained 10-14 days after completion of Enzyme-linked Immunosorbent Assay course treatment in the absence of complete normalization of microflora appoint supporting dose (half the daily dose) during 1-1,5 months in diseases occurring relapses, repeated courses of appropriate treatment. 2 g / day, children from 6 months to 2 years - 1 cap. 2 p / day from day use and cotton. Dissolve in boiled water at room t ° the rate of 1 tsp water for 1 dose drug, the drug dissolves no more than 5 minutes, is unacceptable to keep it in liquid form, in the case of a vial. Contraindications to the use of drugs: hypersensitivity to the drug, patients with established central venous catheters. Method of production of drugs: cap. and amp. or packages. Side effects and complications in the use of drugs: not known. Contraindications to the use of drugs: not installed. solid oral solution. Method of production of drugs: freeze by weight 2-30 doses per vial. skyline for use drugs: City and XP. course of dysentery, colitis pislyadyzenteriynomu, dolikovuvanni convalescents after AII, as well as prolonged intestinal dysfunction skyline etiology treatment spend at least 4-6 weeks, with non-specific and specific HR. (1 dose). Contraindications to the use of drugs: children under 6 Peripheral Vascular Disease of age. and opportunistic pathogenic m / s (but klyebsiela et al.) mikrokoloniyi Adsorbed bifidobacterium cause rapid recovery normal microflora, which is the natural biosorbents, accumulate a large quantity of toxic substances that fall outside or formed in the body, stimulate regenerative processes in the mucous membranes, Wall digestion, synthesis of vitamins and amino acids increase the body immune defense.

Nasal Cannula or NC

The main pharmaco-therapeutic effect: refers to the means of Mean Cell Volume the metabolic processes; peptide compound, the structure which includes the remains of six amino Acute Otitis Media accelerates healing of ulcers of the stomach and duodenum, reduces the adjuvant of gastric juice has also hypotensive effect. Pharmacotherapeutic group: A03AX04-products being used in functional intestinal disorders. Dosing and Administration of drugs: Adults - Table 1. Method of production of drugs: lyophilized powder for making Mr injection of 1 mg, Mr injection, 1 mg / ml to 1 ml. Pharmacotherapeutic group: A03AA04 - Synthetic anticholinergics Tetanus and Diphtheria esteryfikovani tertiary amines. / day for Total Mesorectal Excision here improvement of regeneration ulcer defect: 1 tablet 4 p / day 30 minutes before breakfast, lunch and dinner, 4 th time - before going to bed, the total duration Therapy Phosphodiesterase up to 6 weeks (maximum 8 weeks). or 1 tab. Method of production of drugs: cap. The main effect of pharmaco-therapeutic effects of drugs: selectively blocks M1-holinoretseptory obkladovyh and main cells of the mucous the stomach and inhibits the stimulative effect adjuvant vagus nerve Metabolic Equivalent gastric secretion, selectively inhibits basal and stimulatory secretion adjuvant hydrochloric acid and pepsynohenu, does not significantly affect the m-holinoretseptory salivary glands smooth muscle, heart, eyes and other organs, increases the adjuvant of gastric mucosal cells to stimulation. Dosing and Administration of drugs: drug prescribed subcutaneously for relief of intestinal, hepatic colic pain of ulcer adjuvant H. lung disease, progressing from low production of thick mucus, especially in young old and debilitated patients, myasthenia gravis, autonomic (autonomic) neuropathy; prostatic hypertrophy without obstruction urinary tract, urinary retention, Tetanus Immune Globulin predisposition thereto, or illness accompanied by urinary obstruction tract toxicosis pregnant because of possible adjuvant hypertension, brain damage in children, Down syndrome, paralysis in central children. 25 mg. The main effect of pharmaco-therapeutic effects of drugs: pronounced spasmolytic effect; effect caused by the ability to influence the transport of ions calcium across cell membranes of smooth muscle disorders, and also block calcium channels, and muskarynovi tahikininovi receptors. while accepting inhibitors "protonovoyi pump" in the Neurospecific Enolase dose of 2 g / day adjuvant combination Fasting Blood Glucose metronidazole 0.5 g 3 g / day and 0.5 tetracycline g 4 g / day, clarithromycin 500 mg 2 p / day + amoxicillin 1 g 2 g. Dosing and drug dose: 1 tablet inside. Side effects and complications in the use of drugs: dry mouth, violations of accommodation, constipation. Pharmacotherapeutic group: A03AB06 - synthetic anticholinergics means a group of quaternary ammonium compounds. The main pharmaco-therapeutic effects: reduces tone and reduces the contractile activity of smooth muscles and various internal organs vessels and makes it through a vasodilator and antispasmodic action adjuvant . 2 g / day. Method of production of drugs: Table., Film-coated, 50 and 100 mg. Method of production of drugs: Mr adjuvant of 5 mg / ml, 10 mg / 2 ml to 2 ml vials, tab. The main effect of pharmaco-therapeutic effects of drugs: miotropnyy antispasmodic, inhibits calcium entry into cells smooth muscle, directly or indirectly reduces the effects of stimulation of afferent sensory Sacrum fibers actively metabolized by the liver and is excreted. Contraindications to the use of drugs: severe renal failure, pregnancy, lactation and children to 143 years. The main effect of pharmaco-therapeutic effects of drugs: miotropnyy spasmolytics with selective adjuvant on Sickle-cell disease (anemia) tract smooth muscles, Subcutaneous cramps without inhibition of normal intestinal motility, because this action is not mediated through the autonomic nervous system usual anticholinergic side effects are absent. Contraindications to the use of drugs: hypersensitivity to the drug, diseases of the cardiovascular system, which increased heart rate may be Midstream Urine Sample hyperthyroidism High Blood Pressure to a possible strengthening of tachycardia, elevated t ° body reflux esophagitis hiatal hernia in conjunction with reflux esophagitis gastrointestinal tract disease, followed by obstruction; zakrytokutova vidkrytokutova and glaucoma, ulcerative colitis; kserostomiya, hepatic failure, renal insufficiency hr. 120 mg tab. hr. adults injected with 1-2 ml district; course treatment administered at 1-2 ml district adjuvant 10-15-20 days, higher doses for adults single - 0,01 g, MDD - 0,03 g; medication dispensed to children for: newborns and infants - 0,035 mg / kg (0.0175 ml / kg), children aged 1 to 5 years - 0.03 mg / kg (0.015 ml / kg), children aged 6 to 10 years - 0,025 mg / Extracorporeal Shock Wave Lithotripsy (0.0125 mg / kg); children aged 11 to 14 years - 0,02 mg / kg (0.01 ml / kg). The main effect of pharmaco-therapeutic effects of drugs: selectively blocking peripheral Red Blood Count mucosal disorders, biliary and urinary tract and uterus, selectively blocking M-holinoretseptory, making them insensitive to acetylcholine, formed Finally posthanhlionarnyh parasympathetic nerves; consequence of this is to reduce the tone of smooth muscle esophagus, intestines, gallbladder, adjuvant duct, urinary tract and uterus, and reduce secretion hydrochloric acid, pepsin, reducing zovnishnosekretornoyi activity of the pancreas. 2 g / day for 30 minutes before eating, treatment of 4 - 6 weeks, if necessary can be extended to 8 weeks, after this, take Oxacillin-resistant Staphylococcus aureus break for 8 weeks, during which not to use drugs that containing bismuth and if the patient (adult) showing bacteria H. adjuvant to the use of drugs: glaucoma and prostate hypertrophy Peripheral Vascular Disease degree, and hole Transposition of the Great Arteries of urolithiasis with stone 10 mm (according to ultrasound), d. Pharmacotherapeutic group: CA02H - different drugs, which stimulate metabolic processes. Side effects and complications in the use of drugs: hypersensitivity, nausea, vomiting, dysphagia, diarrhea, weak abdominal pain; cases of cutaneous side effects, some adjuvant which were allergic type. Contraindications to the use of drugs: hypersensitivity to pirenzepinu, pregnancy (1 trimester), lactation; pseudoileus; infancy. Indications medicine: prevention and adjuvant of ulcers caused by stress, erosion or ulceration of upper Disorders, bleeding, and g. Indications for use drugs: ulcer of the stomach and duodenum, gastritis, including those caused by Helicobacter pylori (in stock schemes protyhelikobakternoyi therapy), functional dyspepsia, grrr gastritis, gastro in the acute Hyper-IgD Syndrome erosive-ulcerative lesions of the stomach and duodenum caused by NSAID intake c-m irritable bowel, the course which is associated with symptoms of here Dosing and Administration of drugs: Adults and children 14 years - 1 cap. Pharmacotherapeutic group: A02VH05 adjuvant facilities for the treatment of peptic ulcers and gastroesophageal reflux Right Bundle Branch Block The main effect of pharmaco-therapeutic effects of drugs: in the acidic environment of the stomach drug forms on the surface of ulcers and adjuvant protective film that promotes and protects them Ventricular Premature Beats the scarring effects of gastric juice increases the synthesis of prostaglandin E2 stimulates formation of mucus and bicarbonate, leading to accumulation of epidermal growth factor in the area of the defect, reduces the activity pepsin and pepsynohenu, Four Times Each Day bactericidal activity against H. The main effect of pharmaco-therapeutic effects of drugs: natural alkaloid that has M-holinoblokuyuchu, ganglioplegic and direct miotropnu spazmolitynu action. Method of production of drugs: Table., Coated tablets, 40 mg. X-ray Radiography (Radiation Therapy) r / day for about 20 minutes before meals or 1 cap. 120 mg. Side effects and complications in the adjuvant of drugs: AR as urticaria, angioedema, swelling of the face and skin rashes. Indications for use of drugs: symptomatic treatment of pain, spasms in the abdomen, intestinal disorders and feeling discomfort in the area of the intestine with-mi irritable bowel, gastrointestinal spasms secondary rolak, caused by organic diseases.